Priority Date: 02.02.12 (US 201261594159P)

PROMOTERS FOR INCREASED PROTEIN EXPRESSION IN MENINGOCOCCUS

  • Application ID: EP13703562
  • Status: The patent has been granted

Applicants

Technology company logo small
Technology Company
Technology company logo small
Technology Company

Attorney

no operation time available
2 offices
Technology Company

Specialization

This EP application has the IPC class C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Novartis Vaccines and Diagnostics Srl is specialised in C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 02.02.2012 - Priority Date (US 201261594159P)
  • 08.08.2013 - Publication A1 (WO2013113917)
  • 10.12.2014 - Publication A1 (EP2809785)
  • 01.11.2017 - Publication B1 (EP2809785)

IPC Classification